Instytut Podstawowych Problemów Techniki
Polskiej Akademii Nauk

Partnerzy

Mauricio Trujillo-Roldán


Ostatnie publikacje
1.  Avila-Barrientos Luis P., Cofas-Vargas Luis F., Agüero-Chapin G., García-Hernandez E., Ruiz-Carmona S., Valdez-Cruz Norma A., Trujillo-Roldán M., Weber J., Ruiz-Blanco Yasser B., Barril X., García-Hernández E., Computational Design of Inhibitors Targeting the Catalytic β Subunit of Escherichia coli FOF1-ATP Synthase, Antibiotics, ISSN: 2079-6382, DOI: 10.3390/antibiotics11050557, Vol.11, No.5, pp.557-1-19, 2022

Streszczenie:
With the uncontrolled growth of multidrug-resistant bacteria, there is an urgent need to search for new therapeutic targets, to develop drugs with novel modes of bactericidal action. FoF1-ATP synthase plays a crucial role in bacterial bioenergetic processes, and it has emerged as an attractive antimicrobial target, validated by the pharmaceutical approval of an inhibitor to treat multidrug-resistant tuberculosis. In this work, we aimed to design, through two types of in silico strategies, new allosteric inhibitors of the ATP synthase, by targeting the catalytic β subunit, a centerpiece in communication between rotor subunits and catalytic sites, to drive the rotary mechanism. As a model system, we used the F1 sector of Escherichia coli, a bacterium included in the priority list of multidrug-resistant pathogens. Drug-like molecules and an IF1-derived peptide, designed through molecular dynamics simulations and sequence mining approaches, respectively, exhibited in vitro micromolar inhibitor potency against F1. An analysis of bacterial and Mammalia sequences of the key structural helix-turn-turn motif of the C-terminal domain of the β subunit revealed highly and moderately conserved positions that could be exploited for the development of new species-specific allosteric inhibitors. To our knowledge, these inhibitors are the first binders computationally designed against the catalytic subunit of FOF1-ATP synthase.

Słowa kluczowe:
FOF1-ATP synthase, allosteric inhibition, structure-based drug design, evolutionary and PPI algorithms, peptide design

Afiliacje autorów:
Avila-Barrientos Luis P. - inna afiliacja
Cofas-Vargas Luis F. - inna afiliacja
Agüero-Chapin G. - inna afiliacja
García-Hernandez E. - inna afiliacja
Ruiz-Carmona S. - inna afiliacja
Valdez-Cruz Norma A. - inna afiliacja
Trujillo-Roldán M. - inna afiliacja
Weber J. - inna afiliacja
Ruiz-Blanco Yasser B. - inna afiliacja
Barril X. - inna afiliacja
García-Hernández E. - inna afiliacja
70p.

Kategoria A Plus

IPPT PAN

logo ippt            ul. Pawińskiego 5B, 02-106 Warszawa
  +48 22 826 12 81 (centrala)
  +48 22 826 98 15
 

Znajdź nas

mapka
© Instytut Podstawowych Problemów Techniki Polskiej Akademii Nauk 2024